Skip to content

Isaac Barchas, Director at Immunome, sold IMNM on Aug 12, 2026

Data as of Oct 16

▼ SELL$301K11,048 shares at $27.25Isaac Barchas DirectorIMNM Immunome Inc.
Watch IMNM
Traded
Aug 12, 2026
Disclosed
Aug 12, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Isaac Barchas, Director at Immunome, sold IMNM on Aug 12, 2026TRADEDDISCLOSED
IMNMSimilar stocks (XLV — its sector index fund), rebased to IMNM's price on the disclosure day
IMNM since disclosure
−41.2%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$1.6Mdisclosed Aug 12 · filed 1 day after the trade
  2. ▼ SELLIsaac Barchas DirectorIMNM Immunome Inc.$264Kdisclosed Aug 12 · filed 2 days after the trade

See every trade on IMNM →